T1	Disorder 25 36	sarcoidosis
N1 	Reference T1 UMLS:C0036202	sarcoidosis
T3	Pharmacological_substance 68 77	ribavirin
N1000 	Reference T3 MeSH:D012254	ribavirin
T4	Disorder 102 121	chronic hepatitis C
N2 	Reference T4 UMLS:C0524910	chronic hepatitis C
T5	Disorder 168 179	Sarcoidosis
N3 	Reference T5 UMLS:C0036202	Sarcoidosis
T8	Disorder 321 332	sarcoidosis
N4 	Reference T8 UMLS:C0036202	sarcoidosis
T9	Disorder 354 365	sarcoidosis
N5 	Reference T9 UMLS:C0036202	sarcoidosis
T10	Pharmacological_substance 382 398	interferon alpha
N1001 	Reference T10 MeSH:D016898	interferon alpha
T13	Disorder 449 468	chronic hepatitis C
N6 	Reference T13 UMLS:C0524910	chronic hepatitis C
T14	Disorder 470 473	CHC
N7 	Reference T14 UMLS:C0524910	CHC
T15	Disorder 489 500	sarcoidosis
N8 	Reference T15 UMLS:C0036202	sarcoidosis
T16	Pharmacological_substance 524 540	interferon alpha
N1002 	Reference T16 MeSH:D016898	interferon alpha
T18	Pharmacological_substance 545 554	ribavirin
N1003 	Reference T18 MeSH:D012254	ribavirin
T19	Pharmacological_substance 583 599	interferon alpha
N1004 	Reference T19 MeSH:D016898	interferon alpha
T21	Pharmacological_substance 604 613	ribavirin
N1005 	Reference T21 MeSH:D012254	ribavirin
T22	Pharmacological_substance 706 722	interferon alpha
N1006 	Reference T22 MeSH:D016898	interferon alpha
T24	Disorder 773 781	dyspnoea
N9 	Reference T24 UMLS:C0013404	dyspnoea
T25	Disorder 1033 1060	mediastinal lymphadenopathy
N10 	Reference T25 UMLS:C0520743	mediastinal lymphadenopathy
T26	Disorder 1070 1092	noncaseating granuloma
T27	Disorder 1120 1141	pulmonary sarcoidosis
N11 	Reference T27 UMLS:C0036205	pulmonary sarcoidosis
T28	Disorder 1293 1304	sarcoidosis
N12 	Reference T28 UMLS:C0036202	sarcoidosis
T29	Disorder 1372 1383	hepatitis C
N13 	Reference T29 UMLS:C0019196	hepatitis C
T30	Disorder 1440 1461	pulmonary sarcoidosis
N14 	Reference T30 UMLS:C0036205	pulmonary sarcoidosis
T31	Disorder 1466 1477	hepatitis C
N15 	Reference T31 UMLS:C0019196	hepatitis C
T32	Disorder 1513 1524	sarcoidosis
N16 	Reference T32 UMLS:C0036202	sarcoidosis
T33	Disorder 1540 1559	chronic hepatitis C
N17 	Reference T33 UMLS:C0524910	chronic hepatitis C
T35	Pharmacological_substance 1600 1609	ribavirin
N1007 	Reference T35 MeSH:D012254	ribavirin
T7	Pharmacological_substance 44 63	interferon alpha 2b
N1008 	Reference T7 MeSH:C554127	interferon alpha 2b
N1009 	Reference T7 MeSH:C554158	interferon alpha 2b
T11	Combination 78 89	combination
T38	Disorder 185 229	chronic granulomatous multisystemic disorder
T39	Pharmacological_substance 261 277	interferon gamma
N1010 	Reference T39 MeSH:D007371	interferon gamma
T42	Combination 511 520	treatment
T44	Subject 629 647	50-year-old female
T45	Disorder 653 656	CHC
N18 	Reference T45 UMLS:C0524910	CHC
T46	Combination 560 571	combination
T47	Subject 1560 1568	patients
T49	Speculation_cue 1525 1528	may
T50	Pharmacological_substance 1576 1592	interferon alpha
N1011 	Reference T50 MeSH:D016898	interferon alpha
T6	Disorder 786 791	fever
N19 	Reference T6 UMLS:C0015967	fever
T12	Disorder 751 771	non-productive cough
N20 	Reference T12 UMLS:C0850149	non-productive cough
T20	Coreferring_mention 724 727	She
T34	Pharmacological_substance 1240 1247	steroid
N1012 	Reference T34 MeSH:D013256	steroid
T54	Disorder 899 921	bilateral hilar masses
N21 	Reference T54 UMLS:C0587052	bilateral hilar masses
T55	Disorder 926 947	nodular infiltrations
N22 	Reference T55 UMLS:C0332448	nodular infiltrations
T17	Coreferring_mention 826 845	combination therapy
T51	Subject 439 443	case
